Related Experiment Video
Updated: Feb 5, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Induction and Suppression of Innate Antiviral Responses by Hepatitis A Virus
Xin Cao1,2,3, Yu-Jia Xue1,2, Jiang-Long Du1,2
1College of Life Science and Engineering, Northwest Minzu University, Engineering & Technology Research Center for Animal Cell, Lanzhou, China.
Abstract:
Hepatitis A virus (HAV) belongs to the family Picornaviridae. It is the pathogen of acute viral hepatitis caused by fecal-oral transmission. RNA viruses are sensed by pathogen-associated pattern recognition receptors (PRRs) such as Toll-like receptor 3 (TLR3), retinoic acid-inducible gene I (RIG-I), and melanoma differentiation-associated gene 5 (MDA5). PRR activation leads to production of type 1 interferon (IFN-α/β), serving as the first line of defense against viruses. However, HAV has developed various strategies to compromise the innate immune system and promote viral propagation within the host cells. The long coevolution of HAV in hosts has prompted the development of effective immune antagonism strategies that actively fight against host antiviral responses. Proteases encoded by HAV can cleave the mitochondrial antiviral signaling protein (MAVS, also known as IPS-1, VISA, or Cardif), TIR domain- containing adaptor inducing IFN-β (TRIF, also known as TICAM-1) and nuclear factor-κB (NF-κB) essential modulator (NEMO), which are key adaptor proteins in RIG-I-like receptor (RLR), TLR3 and NF-κB signaling, respectively. In this mini-review, we summarize all the recent progress on the interaction between HAV and the host, especially focusing on how HAV abrogates the antiviral effects of the innate immune system.
Insights
Hepatitis A virus (HAV) evades the innate immune system by targeting key signaling proteins. This review details how HAV proteases disrupt viral defense mechanisms, aiding its replication.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Hepatitis A virus (HAV) causes acute viral hepatitis via fecal-oral transmission.
- RNA viruses trigger innate immunity through pattern recognition receptors (PRRs), initiating antiviral responses like type 1 interferon (IFN-α/β) production.
- HAV has evolved immune evasion strategies to counteract host defenses.
Purpose of the Study:
- To review recent findings on host-HAV interactions.
- To focus on HAV's mechanisms for abrogating innate immune responses.
Main Methods:
- Review of scientific literature on HAV and innate immunity.
- Analysis of HAV's strategies to inhibit host antiviral signaling pathways.
Main Results:
- HAV proteases cleave crucial adaptor proteins: mitochondrial antiviral signaling protein (MAVS), TIR domain-containing adaptor inducing IFN-β (TRIF), and nuclear factor-κB (NF-κB) essential modulator (NEMO).
- Cleavage of these adaptors disrupts RIG-I-like receptor (RLR), TLR3, and NF-κB signaling pathways.
- These disruptions compromise the host's ability to mount an effective antiviral response, facilitating HAV propagation.
Conclusions:
- HAV actively antagonizes host antiviral immunity through protease-mediated cleavage of essential signaling adaptors.
- Understanding these immune evasion tactics is crucial for developing effective therapeutic strategies against Hepatitis A.
More Related Videos
06:28Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
What are Viruses?
The Antiviral System of Bacteria and Archaea: CRISPR
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Responses to Gravity and Touch
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...